| Drug Name | Levera (Daclatasvir) |
|---|---|
| Drug Class |
Anti-viral
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Infectious disease
|
| Risk |
Severe cases of Bradycardia in combination with certain hepatitis C medicines and amiodarone |
| Dear Healthcare provider letter DHPC |
|